Press Releases

Date Title and Summary Additional Formats
Toggle Summary ERAS 2021: CHF Solutions to Host On-Demand Presentation on Management of Fluid Overload in Cardiac Surgery Patients
EDEN PRAIRIE, Minn. , March 04, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, will participate in the first ERAS Cardiac Society Virtual Conference , broadcasting Live from Methodist
View HTML
Toggle Summary CHF Solutions, Inc. Announces 49.5 Percent Increase in Revenue for Fourth Quarter 2020 and Provides Company Update
EDEN PRAIRIE, Minn. , March 02, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter ended December 31, 2020 . Recent Highlights Revenue for the fourth quarter of 2020 was $2 million , an increase of 49.5% compared to the prior year period
View HTML
Toggle Summary CHF Solutions, Inc. To Announce Fourth Quarter 2020 Financial Results on March 2, 2021
EDEN PRAIRIE, Minn. , Feb. 16, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its fourth quarter 2020 financial results will be released on Tuesday, March 2, 2021 . The company will host a conference call and webcast at 9:00 AM ET that morning, during which
View HTML
Toggle Summary CHF Solutions Submits Patent Application for New and Improved Diagnostic Parameters to Support Hemodynamic Stability
EDEN PRAIRIE, Minn. , Feb. 03, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application to increase monitoring capabilities with its Aquadex
View HTML
Toggle Summary CHF Solutions’ Physician-Led Webinar Highlights Real-World Evidence Supporting Effectiveness of Ultrafiltration in Heart Failure Patients
EDEN PRAIRIE, Minn. , Jan. 28, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced key takeaways from its physician-led webinar discussing real-world experience using
View HTML
Toggle Summary CHF Solutions Offers Educational Event on Effective Fluid Management Strategies in Heart Failure Patients
EDEN PRAIRIE, Minn. , Jan. 21, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the company will host an interactive, physician-led webinar to discuss “Real-World Experience
View HTML
Toggle Summary CHF Solutions Appoints Nestor Jaramillo, Jr. as President and Chief Executive Officer
EDEN PRAIRIE, Minn. , Jan. 19, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the appointment of President and Chief Operating Officer Nestor Jaramillo , Jr.
View HTML
Toggle Summary CHF Solutions Protects New Peripheral Vascular Access Catheter with Patent Application
EDEN PRAIRIE, Minn. , Jan. 12, 2021 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced the submission of a patent application for a peripheral vascular access catheter for use with its
View HTML
Toggle Summary CHF Solutions Announces Meta-Analysis Demonstrates Ultrafiltration is Better than Diuretic Therapy for the Management of Volume Overload in ADHF
EDEN PRAIRIE, Minn. , Dec. 15, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced a meta-analysis published in Heart Failure Review s concludes that ultrafiltration (UF) increases
View HTML
Toggle Summary CHF Solutions Announces Webinar on Pediatric Ultrafiltration Therapy hosted by Ladenburg Thalman & Co.
EDEN PRAIRIE, Minn. , Dec. 04, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that Ladenburg Thalman & Co. will host a conference call and webcast at 1:00p.m.
View HTML